金吾财讯 | 中慧生物-B(02627)今日起招股，拟发行3344.26万股H股，其中90%为国际发售，10%为香港发售，另有15%超额配股权。每股招股价介于12.9港元至15.5港元，每手200股，入场费3,131.26港元。中信证券、招银国际为联席保荐人。股份预期将于8月8日挂牌上市。以中间价14.2港元计算，预期集资净额约4.21亿港元，公司拟将其中约63.6%将分配至集团的核心产品的开发及国内外注册；约18.1%将用于集团的其他在研疫苗的开发和注册；约8.4%将分配至改进集团的工艺及商业化能力；约4.9%将分配至集团的技术平台的开发；及约5%将分配至营运资金及其他一般公司用途。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.